Hernández-Alcoceba R - Search Results

1

Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.

Cuevas Y, Hernández-Alcoceba R, Aragones J, Naranjo-Suárez S, Castellanos MC, Esteban MA, Martín-Puig S, Landazuri MO, del Peso L. Cuevas Y, et al. Cancer Res. 2003 Oct 15;63(20):6877-84. Cancer Res. 2003. PMID: 14583486

2

Rho proteins induce metastatic properties in vivo.

del Peso L, Hernández-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, Lacal JC. del Peso L, et al. Oncogene. 1997 Dec 18;15(25):3047-57. doi: 10.1038/sj.onc.1201499. Oncogene. 1997. PMID: 9444953

3

The Ras family of GTPases in cancer cell invasion.

Hernández-Alcoceba R, del Peso L, Lacal JC. Hernández-Alcoceba R, et al. Cell Mol Life Sci. 2000 Jan 20;57(1):65-76. doi: 10.1007/s000180050499. Cell Mol Life Sci. 2000. PMID: 10949581 Free PMC article. Review.

4

Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors.

Zabala M, Wang L, Hernandez-Alcoceba R, Hillen W, Qian C, Prieto J, Kramer MG. Zabala M, et al. Cancer Res. 2004 Apr 15;64(8):2799-804. doi: 10.1158/0008-5472.can-03-3061. Cancer Res. 2004. PMID: 15087396

5

In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.

Hernández-Alcoceba R, Fernández F, Lacal JC. Hernández-Alcoceba R, et al. Cancer Res. 1999 Jul 1;59(13):3112-8. Cancer Res. 1999. PMID: 10397253

6

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.

Bortolanza S, Bunuales M, Alzuguren P, Lamas O, Aldabe R, Prieto J, Hernandez-Alcoceba R. Bortolanza S, et al. Cancer Gene Ther. 2009 Sep;16(9):703-12. doi: 10.1038/cgt.2009.12. Epub 2009 Feb 20. Cancer Gene Ther. 2009. PMID: 19229289 Free article.

7

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.

Hernandez-Alcoceba R, Pihalja M, Qian D, Clarke MF. Hernandez-Alcoceba R, et al. Hum Gene Ther. 2002 Sep 20;13(14):1737-50. doi: 10.1089/104303402760293574. Hum Gene Ther. 2002. PMID: 12396626 Free article.

8

Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells.

Gomes EM, Rodrigues MS, Phadke AP, Butcher LD, Starling C, Chen S, Chang D, Hernandez-Alcoceba R, Newman JT, Stone MJ, Tong AW. Gomes EM, et al. Clin Cancer Res. 2009 Feb 15;15(4):1317-25. doi: 10.1158/1078-0432.CCR-08-1360. Clin Cancer Res. 2009. PMID: 19228733

9

Recent advances in oncolytic virus design.

Hernández-Alcoceba R. Hernández-Alcoceba R. Clin Transl Oncol. 2011 Apr;13(4):229-39. doi: 10.1007/s12094-011-0647-4. Clin Transl Oncol. 2011. PMID: 21493183 Review.

10

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.

Bortolanza S, Qian C, Kramer MG, Gomar C, Prieto J, Farinati F, Hernandez-Alcoceba R. Bortolanza S, et al. J Mol Med (Berl). 2005 Sep;83(9):736-47. doi: 10.1007/s00109-005-0681-1. Epub 2005 Jun 23. J Mol Med (Berl). 2005. PMID: 15976917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters